scispace - formally typeset
F

Frederica P. Perera

Researcher at Columbia University

Publications -  411
Citations -  33903

Frederica P. Perera is an academic researcher from Columbia University. The author has contributed to research in topics: Environmental exposure & Pregnancy. The author has an hindex of 95, co-authored 389 publications receiving 29553 citations. Previous affiliations of Frederica P. Perera include Icahn School of Medicine at Mount Sinai & Natural Resources Defense Council.

Papers
More filters
Journal ArticleDOI

Prenatal exposure to air pollution is associated with altered brain structure, function, and metabolism in childhood.

TL;DR: Prenatal exposure to fine particulate matter and polycyclic aromatic hydrocarbons suggests PM2.5 and PAH disrupt brain development through one or more common molecular pathways, such as inflammation or oxidative stress.
Journal ArticleDOI

Urinary polycyclic aromatic hydrocarbon metabolites among 3-year-old children from Krakow, Poland.

TL;DR: The level of PAHs exposure in children living in Kraków, one of the most polluted cities in Poland, is described and the relationship of urinary biomarkers with environmental PAHsexposure is determined to include 2‐OH‐NAP and 2-OH‐FLUOR.
Journal ArticleDOI

Co-Benefits to Children's Health of the U.S. Regional Greenhouse Gas Initiative.

TL;DR: This innovative analysis indicates that RGGI has provided substantial child health benefits beyond those initially considered, and those health benefits had significant estimated economic value.
Journal ArticleDOI

Prenatal phthalate and early childhood bisphenol A exposures increase asthma risk in inner-city children

TL;DR: In this article, the authors evaluated whether two classes of endocrine disrupting chemicals (EDCs) interact to increase risk of asthma in infants and young children in inner-city children.
Journal ArticleDOI

Circulating pro-surfactant protein B as a risk biomarker for lung cancer

TL;DR: A nonlinear, J-shaped association between plasma pro-SFTPB levels and lung cancer risk is suggested, with both nondetectable and higher levels of the marker being associated with lung cancer.